These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19031069)

  • 1. The target cell response to cytokines governs the autoreactive T cell repertoire in the pancreas of NOD mice.
    Hultcrantz M; Jacobson S; Hill NJ; Santamaria P; Flodström-Tullberg M
    Diabetologia; 2009 Feb; 52(2):299-305. PubMed ID: 19031069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
    Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
    J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-21 regulates SOCS1 expression in autoreactive CD8
    Sutherland APR; Graham KL; Papadimitriou M; Jhala G; Trivedi P; Catterall T; Fynch S; Kay TWH; Thomas HE
    Sci Rep; 2019 Oct; 9(1):15302. PubMed ID: 31653894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.
    Solomon M; Flodström-Tullberg M; Sarvetnick N
    Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.
    Ejrnaes M; Videbaek N; Christen U; Cooke A; Michelsen BK; von Herrath M
    J Immunol; 2005 Mar; 174(5):2746-55. PubMed ID: 15728483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse.
    Flodström-Tullberg M; Yadav D; Hägerkvist R; Tsai D; Secrest P; Stotland A; Sarvetnick N
    Diabetes; 2003 Nov; 52(11):2696-700. PubMed ID: 14578288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.
    Augstein P; Dunger A; Heinke P; Wachlin G; Berg S; Hehmke B; Salzsieder E
    Biochem Biophys Res Commun; 2003 May; 304(2):378-84. PubMed ID: 12711326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.
    Ablamunits V; Elias D; Cohen IR
    Clin Exp Immunol; 1999 Feb; 115(2):260-7. PubMed ID: 9933451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool.
    Serreze DV; Johnson EA; Chapman HD; Graser RT; Marron MP; DiLorenzo TP; Silveira P; Yoshimura Y; Nathenson SG; Joyce S
    Diabetes; 2001 Sep; 50(9):1992-2000. PubMed ID: 11522664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes.
    Ploix C; Bergerot I; Fabien N; Perche S; Moulin V; Thivolet C
    Diabetes; 1998 Jan; 47(1):39-44. PubMed ID: 9421372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P
    Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.
    Ploix C; Bergerot I; Durand A; Czerkinsky C; Holmgren J; Thivolet C
    Diabetes; 1999 Nov; 48(11):2150-6. PubMed ID: 10535448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes.
    Jörns A; Arndt T; Meyer zu Vilsendorf A; Klempnauer J; Wedekind D; Hedrich HJ; Marselli L; Marchetti P; Harada N; Nakaya Y; Wang GS; Scott FW; Gysemans C; Mathieu C; Lenzen S
    Diabetologia; 2014 Mar; 57(3):512-21. PubMed ID: 24310561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
    Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
    J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effects of cytokines on pancreatic beta-cells in models of type I diabetes dependent on CD4(+) T lymphocytes.
    Angstetra E; Graham KL; Emmett S; Dudek NL; Darwiche R; Ayala-Perez R; Allison J; Santamaria P; Kay TW; Thomas HE
    Immunol Cell Biol; 2009 Feb; 87(2):178-85. PubMed ID: 19015667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice.
    Tominaga Y; Nagata M; Yasuda H; Okamoto N; Arisawa K; Moriyama H; Miki M; Yokono K; Kasuga M
    Clin Immunol Immunopathol; 1998 Feb; 86(2):209-18. PubMed ID: 9473384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKG2D blockade prevents autoimmune diabetes in NOD mice.
    Ogasawara K; Hamerman JA; Ehrlich LR; Bour-Jordan H; Santamaria P; Bluestone JA; Lanier LL
    Immunity; 2004 Jun; 20(6):757-67. PubMed ID: 15189740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
    Chen MC; Proost P; Gysemans C; Mathieu C; Eizirik DL
    Diabetologia; 2001 Mar; 44(3):325-32. PubMed ID: 11317664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent Diabetes.
    Fishman S; Lewis MD; Siew LK; De Leenheer E; Kakabadse D; Davies J; Ziv D; Margalit A; Karin N; Gross G; Wong FS
    Mol Ther; 2017 Feb; 25(2):456-464. PubMed ID: 28109957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.